{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T11:02:42Z","timestamp":1760266962202},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,9,3]],"date-time":"2009-09-03T00:00:00Z","timestamp":1251936000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1007\/s10238-009-0061-1","type":"journal-article","created":{"date-parts":[[2009,9,2]],"date-time":"2009-09-02T18:27:59Z","timestamp":1251916079000},"page":"27-31","source":"Crossref","is-referenced-by-count":10,"title":["In vivo modulation of the expressions of Fas and CD25 by intravenous immunoglobulin in common variable immunodeficiency"],"prefix":"10.1007","volume":"10","author":[{"given":"Hasibe","family":"Artac","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reyhan","family":"Kara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ismail","family":"Reisli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,9,3]]},"reference":[{"key":"61_CR1","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.molimm.2004.07.046","volume":"42","author":"R Lemieux","year":"2005","unstructured":"Lemieux R, Bazin R, Sonia N (2005) Therapeutic intravenous immunoglobulins. Mol Immunol 42:839\u2013848","journal-title":"Mol Immunol"},{"key":"61_CR2","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S1246-7820(03)00035-1","volume":"10","author":"J Bayry","year":"2003","unstructured":"Bayry J, Misra N, Latry V, Prost F, Delignat S, Lacroix-Desmazes S, Kazatchkine MD, Kaveri SV (2003) Mechanisms of action of intravenous immunoglobulins in autoimmune and inflammatory diseases. Transfus Clin Biol 10:165\u2013169","journal-title":"Transfus Clin Biol"},{"key":"61_CR3","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1056\/NEJMra993360","volume":"345","author":"MD Kazatchkine","year":"2001","unstructured":"Kazatchkine MD, Kaveri SV (2001) Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. N Engl J Med 345:747\u2013755","journal-title":"N Engl J Med"},{"key":"61_CR4","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.autrev.2008.04.012","volume":"7","author":"JF Seite","year":"2008","unstructured":"Seite JF, Shoenfeld Y, Youinou P, Hillion S (2008) What is the content of the magic draft IVIg? Autoimmun Rev 7:435\u2013439","journal-title":"Autoimmun Rev"},{"key":"61_CR5","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1385\/CRIAI:29:3:185","volume":"29","author":"T Sapir","year":"2005","unstructured":"Sapir T, Shoenfeld Y (2005) Facing the enigma of immunomodulatory effects of intravenous immunoglobulin. Clin Rev Allergy Immunol 29:185\u2013199","journal-title":"Clin Rev Allergy Immunol"},{"key":"61_CR6","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1126\/science.7533326","volume":"267","author":"S Nagata","year":"1995","unstructured":"Nagata S, Golstein P (1995) The Fas death factor. Science 267:1449\u20131456","journal-title":"Science"},{"key":"61_CR7","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.4049\/jimmunol.161.7.3781","volume":"161","author":"NK Prasad","year":"1998","unstructured":"Prasad NK, Papoff G, Zeuner A, Bonnin E, Kazatchkine MD, Ruberti G, Kaveri SV (1998) Therapeutic preparations of normal polyspecific IgG (IVIg) induce apoptosis in human lymphocytes and monocytes: a novel mechanism of action of IVIg involving the Fas apoptotic pathway. J Immunol 161:3781\u20133790","journal-title":"J Immunol"},{"key":"61_CR8","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.jaci.2003.09.045","volume":"112","author":"F Altznauer","year":"2003","unstructured":"Altznauer F, Von Gunter S, Spath P, Simon HU (2003) Concurrent presence of agonistic and antagonistic anti-CD95 autoantibodies in intravenous Ig preparations. J Allergy Clin Immunol 112:1185\u20131190","journal-title":"J Allergy Clin Immunol"},{"key":"61_CR9","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1126\/science.282.5388.490","volume":"282","author":"I Viard","year":"1998","unstructured":"Viard I, Wehrli P, Bullani R, Schneider P, Holler N, Salomon D, Hunziker T, Saurat JH, Tschopp J, French LE (1998) Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science 282:490\u2013493","journal-title":"Science"},{"key":"61_CR10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2332\/allergolint.55.9","volume":"55","author":"LE French","year":"2006","unstructured":"French LE (2006) Toxic epidermal necrolysis and Stevens Johnson syndrome: our current understanding. Allergol Int 55:9\u201316","journal-title":"Allergol Int"},{"issue":"suppl 1","key":"61_CR11","first-page":"1","volume":"118","author":"International Union of Immunological Societies","year":"1999","unstructured":"International Union of Immunological Societies (1999) Primary immunodeficiency diseases. Report of an IUIS Scientific Committee. Clin Exp Immunol 118(suppl 1):1\u201328","journal-title":"Clin Exp Immunol"},{"key":"61_CR12","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1046\/j.1365-2249.1999.00924.x","volume":"116","author":"WA Sewell","year":"1999","unstructured":"Sewell WA, North ME, Cambronero R, Webster AD, Farrant J (1999) In vivo modulation of cytokine synthesis by intravenous immunoglobulin. Clin Exp Immunol 116:509\u2013515","journal-title":"Clin Exp Immunol"},{"key":"61_CR13","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0002-9343(87)90752-2","volume":"81","author":"WB White","year":"1987","unstructured":"White WB, Desbonnet CR, Ballow M (1987) Immunoregulatory effects of intravenous immune serum globulin therapy in common variable hypogammaglobulinemia. Am J Med 81:431\u2013436","journal-title":"Am J Med"},{"key":"61_CR14","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0091-6749(89)90196-6","volume":"84","author":"M Ballow","year":"1989","unstructured":"Ballow M, White W, Desbonnet C (1989) Modulation of in vitro synthesis of immunoglobulin and the induction of suppressor activity by therapy with intravenous immunoglobulin. J Allergy Clin Immunol 84:595\u2013601","journal-title":"J Allergy Clin Immunol"},{"key":"61_CR15","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.tracli.2006.02.023","volume":"12","author":"D Berlana","year":"2005","unstructured":"Berlana D, Vidaller A, J\u00f3dar R, Fort E, Domingo A, Past\u00f3 L (2005) Changes in biochemical, hematological and immunological profiles after low-dose intravenous immunoglobulin administration in patients with hypogammaglobulinemia. Transfus Clin Biol 12:433\u2013440","journal-title":"Transfus Clin Biol"},{"key":"61_CR16","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1006\/clim.1999.4799","volume":"93","author":"ME Conley","year":"1999","unstructured":"Conley ME, Notarangelo LD, Etzioni A (1999) Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol 93:190\u2013197","journal-title":"Clin Immunol"},{"key":"61_CR17","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/(SICI)1097-0320(19970615)30:3<124::AID-CYTO3>3.0.CO;2-L","volume":"30","author":"X Bossuyt","year":"1997","unstructured":"Bossuyt X, Marti GE, Fleisher TA (1997) Comparative analysis of whole blood lysis methods for flow cytometry. Cytometry 30:124\u2013133","journal-title":"Cytometry"},{"issue":"suppl 1","key":"61_CR18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/cei.1996.104.s1.3","volume":"104","author":"L Mouthon","year":"1996","unstructured":"Mouthon L, Kaveri SV, Spalter SH, Lacroix-Desmazes S, Lefranc C, Desai R, Kazatchkine MD (1996) Mechanisms of action of intravenous immune globulin in immune-mediated diseases. Clin Exp Immunol 104(suppl 1):3\u20139","journal-title":"Clin Exp Immunol"},{"key":"61_CR19","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1001\/archneur.56.6.661","volume":"56","author":"M Stangel","year":"1999","unstructured":"Stangel M, Toyka KV, Gold R (1999) Mechanisms of high-dose intravenous immunoglobulins in demyelinating diseases. Arch Neurol 56:661\u2013663","journal-title":"Arch Neurol"},{"key":"61_CR20","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1034\/j.1600-6143.2003.00011.x","volume":"3","author":"M Toyoda","year":"2003","unstructured":"Toyoda M, Pao A, Petrosian A, Jordan SC (2003) Pooled human gammaglobulin modulates surface molecule expression and induces apoptosis in human B cells. Am J Transplant 3:156\u2013166","journal-title":"Am J Transplant"},{"key":"61_CR21","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.autrev.2008.03.015","volume":"7","author":"S Gunten von","year":"2008","unstructured":"von Gunten S, Simon HU (2008) Natural anti-Siglec autoantibodies mediate potential immunoregulatory mechanisms: implications for the clinical use of intravenous immunoglobulins (IVIg). Autoimmun Rev 7:453\u2013456","journal-title":"Autoimmun Rev"},{"key":"61_CR22","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/BF00920789","volume":"12","author":"IN Schaik Van","year":"1992","unstructured":"Van Schaik IN, Lundkvist I, Vermeulen M, Brand A (1992) Polyvalent immunoglobulin for intravenous use interferes with cell proliferation in vitro. J Clin Immunol 12:325\u2013334","journal-title":"J Clin Immunol"},{"key":"61_CR23","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/jnnp.57.Suppl.15","volume":"57","author":"IN Schaik Van","year":"1994","unstructured":"Van Schaik IN, Vermeulen M, Brand A (1994) In vitro effects of polyvalent immunoglobulin for intravenous use. J Neurol Neurosurg Psychiatry 57:15\u201317","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"61_CR24","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1084\/jem.178.6.2231","volume":"178","author":"MR Alderson","year":"1993","unstructured":"Alderson MR, Armitage RJ, Maraskovsky E, Tough TW, Roux E, Schooley K, Ramsdell F, Lynch DH (1993) Fas transduces activation signals in normal human T lymphocytes. J Exp Med 178:2231\u20132235","journal-title":"J Exp Med"},{"key":"61_CR25","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1046\/j.1365-2249.1999.00946.x","volume":"117","author":"J Iglesias","year":"1999","unstructured":"Iglesias J, Matamoros N, Raga S, Ferrer JM, Mila J (1999) CD95 expression and function on lymphocyte subpopulations in common variable immunodeficiency (CVID): related to increased apoptosis. Clin Exp Immunol 117:138\u2013146","journal-title":"Clin Exp Immunol"},{"key":"61_CR26","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1046\/j.1365-2249.2000.01239.x","volume":"120","author":"M Di Renzo","year":"2000","unstructured":"Di Renzo M, Zhou Z, George I, Becker K, Cunningham-Rundles C (2000) Enhanced apoptosis of T cells in common variable immunodeficiency. Role defective CD28 costimulation. Clin Exp Immunol 120:503\u2013511","journal-title":"Clin Exp Immunol"},{"key":"61_CR27","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1046\/j.1365-2249.2001.01560.x","volume":"125","author":"M Di Renzo","year":"2001","unstructured":"Di Renzo M, Serrano D, Zhou Z, George I, Becker K, Cunningham-Rundles C (2001) Enhanced T-cell apoptosis in common variable immunodeficiency: negative role of the Fas\/Fasligand system and of the Bcl-2 family proteins and possible role of TNF-RS. Clin Exp Immunol 125:117\u2013122","journal-title":"Clin Exp Immunol"},{"key":"61_CR28","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S0165-5728(01)00243-0","volume":"114","author":"O Aktas","year":"2001","unstructured":"Aktas O, Waiczies S, Grieger U, Wendling U, Zschenderlein R, Zipp F (2001) Polyspecific immunoglobulins (IVIg) suppress proliferation of human (auto) antigen-specific T cells without inducing apoptosis. J Neuroimmunol 114:160\u2013167","journal-title":"J Neuroimmunol"},{"key":"61_CR29","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1399-3038.2005.00344.x","volume":"17","author":"KH Wu","year":"2006","unstructured":"Wu KH, Wu WM, Lu MY, Chiang BL (2006) Inhibitory effect of pooled human immunoglobulin on cytokine production in peripheral blood mononuclear cells. Pediatr Allergy Immunol 17:60\u201368","journal-title":"Pediatr Allergy Immunol"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-009-0061-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10238-009-0061-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-009-0061-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T15:45:07Z","timestamp":1685115907000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10238-009-0061-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9,3]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["61"],"URL":"https:\/\/doi.org\/10.1007\/s10238-009-0061-1","relation":{},"ISSN":["1591-8890","1591-9528"],"issn-type":[{"value":"1591-8890","type":"print"},{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9,3]]}}}